1Bonetti PO, Lennan LO, Napoli C, et al. Statin effects beyond lipid lowering: are they clinically relevant [J]? Eur Heart J, 2003,24:225-248.
2Refolo LM, Pappolla MA, Malester B, et al. Hypercholesterolemia accelerates the Alzheimer' s amyloid pathology in a transgenic mousemodel[J]. Neurobiol Dis,2000,7:321-331.
3Korjo E, Gimpl G, Lammich S, et al. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM10[J]. Proc Natl Acad Sci USA,2001,98:5815-5820.
4Kivipelto M, Helkala EL, Laakse MP, et al. Midlife vascular risk factors and Alzheimer's disease in later life: a population based study[J]. BMJ,2001, 322: 1447-1451.
5Reitz C,Tang MX, Luehsinger J. Relation of plasma lipids to Alzheimet disease and vascular dementia[J]. Arch Neurol, 2004,61: 705-714.
10Sun YX, Crisby M, Lindgren S. Pravastatin inhibits pro-inflammatory effects of ADA Aβ(1-42) in glioma cell culture in vitro [J]. Phannacol Res, 2003,47: 119-126.
2[1]Shen ZX,Ding Q,Wei CZ,et al.CSF cholinesterase in early-onset and late-onset Alzheimer's disease and multi-infarct dementia of Chinese patients.Acta Neurol Scand,1993,87(1):19
3[2]Elble R,Giacobini E,Higgins C.Choline levels are increased in cerebrospinal fluid of Alzheimer's disease.Neurobiol Aging,1989,10(1):45
4[3]Marquis JK,Volicer L,Mark KA,et al.Cholinesterase activity in plasma,erythrocytes and cerebrospinal fluid of patients with dementia of the Alzheimer type.Biol Psychiatry,1985,20(6):605
5[4]Kuo YM,Emmerling MR,Bisgaier CL,et al.Elevated low-density lipoprotein in Alzheimer's disease correlates with brain Aβ1-42 levels.Biochem Biophys Res Commun,1998,252(3):711
6Kim JS, Yoon SS, Kim YH, et al. Serial measurement of interleukin-6,transforming growth factor-β, and S-100 protein in patients with acute stroke. Stroke,1996, 27: 1553-1557.
7Vila N, Castillo J, Davalos A, et al. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke,2000, 31: 2325-2329.
8Albert MA, Danielson E, Rifai N, et al . Effect of therapy on C-reactive protein levels, the pravastatin inflammation/CRP evaluation (PRINCE) : a randomized trial and cohort study . JAMA,2001,286:64-70.
9Riesen WF, Engler H, Risch M, et al. Short-term effects of atorvastatin on C-reactive protein. European Heart, 2002,23:794-799.
10Yu H, Rifai N. High-sensitivity C-reactive protein and atherosclerosis:from theory to therapy.Clin Biochem, 2000, 8:601-610.
